Analysts Set Herbalife Ltd (NYSE:HLF) Target Price at $17.75

Shares of Herbalife Ltd (NYSE:HLF) have been assigned a consensus recommendation of “Hold” from the seven ratings firms that are currently covering the firm, MarketBeat reports. Four analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average twelve-month price target among brokers that have issued ratings on the stock in the last year is $17.40.

Several equities analysts have recently issued reports on the company. Wall Street Zen raised Herbalife from a “buy” rating to a “strong-buy” rating in a research note on Saturday, April 18th. Zacks Research lowered Herbalife from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 20th. Citigroup restated a “buy” rating and set a $21.00 price target (up from $17.00) on shares of Herbalife in a research report on Thursday, February 19th. Maxim Group began coverage on Herbalife in a research report on Tuesday, January 6th. They set a “buy” rating and a $20.00 price target on the stock. Finally, Mizuho lifted their price target on Herbalife from $13.00 to $15.00 and gave the company a “neutral” rating in a research report on Monday, March 30th.

Institutional Investors Weigh In On Herbalife

Several hedge funds have recently made changes to their positions in the company. Geode Capital Management LLC boosted its position in shares of Herbalife by 1.0% during the fourth quarter. Geode Capital Management LLC now owns 2,577,634 shares of the company’s stock valued at $33,231,000 after purchasing an additional 25,783 shares in the last quarter. Iridian Asset Management LLC CT boosted its position in shares of Herbalife by 9.9% during the third quarter. Iridian Asset Management LLC CT now owns 2,449,155 shares of the company’s stock valued at $20,671,000 after purchasing an additional 220,896 shares in the last quarter. Quantedge Capital Pte Ltd boosted its position in shares of Herbalife by 5.2% during the fourth quarter. Quantedge Capital Pte Ltd now owns 2,249,683 shares of the company’s stock valued at $28,998,000 after purchasing an additional 111,700 shares in the last quarter. Solel Partners LP boosted its position in shares of Herbalife by 18.7% during the second quarter. Solel Partners LP now owns 1,669,405 shares of the company’s stock valued at $14,390,000 after purchasing an additional 262,614 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its position in shares of Herbalife by 3.8% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,451,749 shares of the company’s stock valued at $18,713,000 after purchasing an additional 52,642 shares in the last quarter.

Herbalife Stock Performance

HLF opened at $16.30 on Friday. Herbalife has a 52-week low of $6.52 and a 52-week high of $20.40. The stock has a market capitalization of $1.69 billion, a PE ratio of 7.41, a price-to-earnings-growth ratio of 0.99 and a beta of 0.98. The stock’s 50 day moving average price is $16.16 and its 200-day moving average price is $14.05.

Herbalife (NYSE:HLF) last posted its earnings results on Thursday, February 19th. The company reported $0.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.48 by ($0.03). Herbalife had a net margin of 4.53% and a negative return on equity of 35.02%. The business had revenue of $1.28 billion for the quarter, compared to analysts’ expectations of $1.24 billion. During the same period last year, the firm posted $0.36 earnings per share. Herbalife’s quarterly revenue was up 6.3% on a year-over-year basis. Research analysts forecast that Herbalife will post 2.52 EPS for the current fiscal year.

Herbalife Company Profile

Herbalife Nutrition Ltd. (NYSE: HLF) operates as a global multi-level marketing company specializing in weight-management, nutritional supplement, sports nutrition and personal care products. Its portfolio includes protein shakes, vitamins, energy and fitness supplements, hydration products and skin and hair care items, all formulated to support wellness, performance and healthy living. Products are manufactured in GMP-certified facilities to ensure consistent quality and safety standards.

Founded in 1980 by Mark R.